News
COVID, Moderna
Digest more
CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
This update covers the latest health sector developments, including Moderna's COVID-19 vaccine review, GSK's asthma drug FDA ...
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1389.55 with a total volume of ...
11don MSN
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...
This summary provides insights into key developments in the health sector, covering successful Hong Kong listings, animal ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results